Ellison Mark Jason Heath
Insider CIK 1781982 · OPNT Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 7,200 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 8,250 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 10,750 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 11,736 | $20.00 | $234.7K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2023-03-02 | 2023-03-03 | 2,000 | — | $0 | 2,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 2,000 | $20.00 | $40.0K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 9,680 | $20.00 | $193.6K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 7,015 | $20.00 | $140.3K | 11,736 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2023-01-27 | 2023-01-31 | 610 | $20.26 | $12.4K | 18,751 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2023-01-09 | 2023-01-09 | 469 | $20.20 | $9.5K | 19,361 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2023-01-05 | 2023-01-05 | 1,806 | $20.20 | $36.5K | 19,830 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-06-27 | 2022-06-29 | 2,000 | — | $0 | 21,636 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-01-04 | 2022-01-05 | 12,000 | — | $0 | 19,636 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2021-01-26 | 2021-01-27 | 10,750 | — | $0 | 10,750 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-01-26 | 2021-01-27 | 2,236 | — | $0 | 2,236 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-01-26 | 2021-01-27 | 5,400 | — | $0 | 7,636 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2020-01-07 | 2020-01-09 | 8,250 | — | $0 | 8,250 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2020-01-07 | 2020-01-09 | 4,150 | — | $0 | 9,680 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2019-07-29 | 2019-07-30 | 30,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2019-07-29 | 2019-07-30 | 30,000 | $10.00 | $300.0K | 30,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | F Tax w/h | 2019-07-29 | 2019-07-30 | 24,470 | $12.26 | $300.0K | 5,530 | SEC↗ |